Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Companion Pharma
AddedMar 20, 2024
UpdatedJun 18, 2026
Companion Pharma

Companion Pharma

Angel

Innovative animal health products for companion animals in St. Louis.

HQ
St. Louis, MO, US
Founded
2012
Overview
Compare
Fundraising
Employees

Companion Pharma is an animal health product development company that will develop innovative new formulations of drugs for use under prescription in companion animals.

Companion will specifically target companion animal disease indications that have a high unmet treatment need and will provide 'pet friendly' drugs that are proven to work safely in the target species, are formulated in a way to provide ease of administration and are available in doses that meet the needs of the highly variable weight profile of companion animal pets.

Companion Pharma - Similar Companies

Patients' & Consumers' Pharma logo

Patients' & Consumers' Pharma

Skyline Vet Pharma logo

Skyline Vet Pharma

WayPath Pharma logo

WayPath Pharma

waypathpharma.com

Stason Animal Health logo

Stason Animal Health

Zoo Pharma Dynamics logo

Zoo Pharma Dynamics

Pinpoint Pharma logo

Pinpoint Pharma

pinpointpharma.co

Fidelis Pharmaceuticals logo

Fidelis Pharmaceuticals

fidelisrx.com

Animal Life Sciences logo

Animal Life Sciences

Elanco Animal Health logo

Elanco Animal Health

VetDC logo

VetDC

Amerigen Pharmaceuticals logo

Amerigen Pharmaceuticals

amerigenpharma.com

Vetsource logo

Vetsource

Veterinary Prime logo

Veterinary Prime

Aniluxx Biotechnology logo

Aniluxx Biotechnology

aniluxx.com

Merck Animal Health logo

Merck Animal Health

Companion Pharma - Quick Facts

Who are Companion Pharma's competitors?

Companies similar to Companion Pharma include Patients' & Consumers' Pharma, Skyline Vet Pharma, WayPath Pharma and Stason Animal Health.

When was Companion Pharma founded?

Companion Pharma was founded in 2012.

Where is Companion Pharma's headquarters located?

Companion Pharma's headquarters is located in St. Louis, MO, US.

When was Companion Pharma's last funding round?

Companion Pharma's most recent funding round was for $60k (USD) in August 2012.

How much has Companion Pharma raised to-date?

As of Aug 1, 2012, Companion Pharma has raised a total of $110k (USD).

How many employees does Companion Pharma have?

Companion Pharma has 6 employees as of Feb 4, 2024.

Companion Pharma - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Animal Health
  • Pet Pharmaceuticals
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research